B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SARS-CoV-1-mediated effects on programmed cell death

REACTOME PATHWAY
Reactome: R-HSA-96929132 genes11 compounds

The SARS-CoV-1-mediated effects on programmed cell death pathway (Reactome ID: R-HSA-9692913) involves 2 genes and is affected by 11 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

BCL2L1RIPK3

Compounds Affecting SARS-CoV-1-mediated effects on programmed cell death

#CompoundTargets HitStudies
1paxilline42
2Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).300
3Anthralin299
4Aurintricarboxylic Acid184
5Domperidone299
6Metergoline144
7Masoprocol300
8Oxytetracycline300
9Tetracycline300
10vinblastine sulfate81
11Vemurafenib298

About the SARS-CoV-1-mediated effects on programmed cell death Pathway

The SARS-CoV-1-mediated effects on programmed cell death pathway is catalogued in Reactome (ID: R-HSA-9692913) and involves 2 genes. In the BiohacksAI corpus, 11 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BCL2L1, RIPK3.